82 FR 31784 - Sunshine Act Meeting

INTERNATIONAL TRADE COMMISSION

Federal Register Volume 82, Issue 130 (July 10, 2017)

Page Range		31784-31784
FR Document		2017-14450

Federal Register, Volume 82 Issue 130 (Monday, July 10, 2017)

[Federal Register Volume 82, Number 130 (Monday, July 10, 2017)]
[Notices]
[Page 31784]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-14450]


=======================================================================
-----------------------------------------------------------------------

 INTERNATIONAL TRADE COMMISSION

[USITC SE-17-027]


Sunshine Act Meeting

AGENCY HOLDING THE MEETING: United States International Trade 
Commission.

TIME AND DATE: July 12, 2017 at 11:00 a.m.

PLACE: Room 101, 500 E Street SW., Washington, DC 20436, Telephone: 
(202) 205-2000.

STATUS: Open to the public.

MATTERS TO BE CONSIDERED: 
    1. Agendas for future meetings: None.
    2. Minutes.
    3. Ratification List.
    4. Vote in Inv. No. 731-TA-410 (Fourth Review) (Light-Walled 
Rectangular Pipe from Taiwan). The Commission is currently scheduled to 
complete and file its determination and views of the Commission by July 
25, 2017.
    5. Vote in Inv. No. 731-TA-703 (Fourth Review) (Furfuryl Alcohol 
from China). The Commission is currently scheduled to complete and file 
its determination and views of the Commission by July 28, 2017.
    6. Outstanding action jackets: None.
    In accordance with Commission policy, subject matter listed above, 
not disposed of at the scheduled meeting, may be carried over to the 
agenda of the following meeting.

    By order of the Commission.

     Issued: July 5, 2017.
William R. Bishop,
Supervisory Hearings and Information Officer.
[FR Doc. 2017-14450 Filed 7-6-17; 11:15 am]
BILLING CODE 7020-02-P

31784 Federal Register / Vol. 82, No. 130 / Monday, July 10, 2017 / Notices

inhibitory nucleic acids to cells in a Dated: June 27, 2017. STATUS: Open to the public.
targeted and efficient manner are Richard U. Rodriguez, MATTERS TO BE CONSIDERED:
disclosed in this invention. The Associate Director, Technology Transfer 1. Agendas for future meetings: none.
complexes and methods are based on Center, National Cancer Institute. 2. Minutes.
utilizing a cell surface receptor targeting [FR Doc. 2017–14370 Filed 7–7–17; 8:45 am] 3. Ratification List.
ligand and a nucleic acid binding BILLING CODE 4140–01–P 4. Vote in Inv. Nos. 701–TA–579–580
domain that binds an inhibitory nucleic and 731–TA–1369–1373
acid, to efficiently deliver the inhibitory (Preliminary)(Fine Denier Polyester
oligonucleotide to the cell that INTERNATIONAL TRADE Staple Fiber from China, India, Korea,
expresses the cell surface receptor COMMISSION Taiwan, and Vietnam). The Commission
targeting ligand. The compositions can is currently scheduled to complete and
be used to silence gene expression in a [USITC SE–17–027]
file its determinations on July 17, 2017;
cell or to deliver agents to a target cell, views of the Commission are currently
thereby treating or preventing a disease Sunshine Act Meeting
scheduled to be completed and filed on
or disorder. AGENCY HOLDING THE MEETING: United July 24, 2017.
The invention has broad utility as the 5. Vote in Inv. Nos. 701–TA–581 and
States International Trade Commission.
cell surface receptor targeting ligand 731–TA–1374–1376 (Preliminary)
could be any molecule such as, TIME AND DATE: July 12, 2017 at 11:00
a.m. (Citric Acid and Certain Citrate Salts
cytokines, chemokines, antibodies or from Belgium, Colombia, and Thailand).
growth factors, that binds to a unique PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone: The Commission is currently scheduled
cellular receptor or cell surface antigen.
(202) 205–2000. to complete and file its determinations
Cytokines are small secreted proteins
on July 17, 2017; views of the
which mediate and regulate immunity, STATUS: Open to the public.
Commission are currently scheduled to
inflammation, and hematopoiesis. MATTERS TO BE CONSIDERED: be completed and filed on July 24, 2017.
Chemokines are a family of small 1. Agendas for future meetings: None. 6. Outstanding action jackets: None.
cytokines that are secreted by cells. 2. Minutes.
In accordance with Commission
They act on their target cells by binding 3. Ratification List.
4. Vote in Inv. No. 731–TA–410 policy, subject matter listed above, not
specific membrane receptors. TARC/
(Fourth Review) (Light-Walled disposed of at the scheduled meeting,
CCL17 and RANTES/CCL5 are examples
of chemokines whose receptors are Rectangular Pipe from Taiwan). The may be carried over to the agenda of the
CCR4 and CCR5, respectively. Commission is currently scheduled to following meeting.
The complexes of this invention complete and file its determination and By order of the Commission.
could inactivate immune cells by views of the Commission by July 25, Issued: July 5, 2017.
delivering oligonucleotides. For 2017. William R. Bishop,
example, the TARC-nucleic acid 5. Vote in Inv. No. 731–TA–703 Supervisory Hearings and Information
binding domain complex referred to as (Fourth Review) (Furfuryl Alcohol from Officer.
TARC-arp, has been shown to deliver si- China). The Commission is currently [FR Doc. 2017–14449 Filed 7–6–17; 11:15 am]
FoxP3 oligonucleotide into CCR4- scheduled to complete and file its BILLING CODE 7020–02–P
expressing cancer cells that will determination and views of the
specifically only inactivate FoxP3 Commission by July 28, 2017.
expression. Chemokine-based gene 6. Outstanding action jackets: None.
silencing can be therapeutically used to In accordance with Commission DEPARTMENT OF JUSTICE
modulate immune cells and improve policy, subject matter listed above, not [OMB Number 1122–0029]
outcome of diseases, such as by disposed of at the scheduled meeting,
inactivating Tregs to block cancer may be carried over to the agenda of the Agency Information Collection
escape and metastasis. following meeting. Activities; Proposed eCollection
This notice is made in accordance By order of the Commission.
eComments Requested; Extension of a
with 35 U.S.C. 209 and 37 CFR part 404. Currently Approved Collection
Issued: July 5, 2017.
The prospective Exclusive Patent
License will be royalty bearing and may William R. Bishop, AGENCY: Office on Violence Against
be granted unless within fifteen (15) Supervisory Hearings and Information Women, Department of Justice.
days from the date of this published Officer. ACTION: 30-day notice.
notice, the National Cancer Institute [FR Doc. 2017–14450 Filed 7–6–17; 11:15 am]
SUMMARY: The Department of Justice,
receives written evidence and argument BILLING CODE 7020–02–P
Office on Violence Against Women
that establishes that the grant of the
(OVW) will be submitting the following
license would not be consistent with the
UNITED STATES INTERNATIONAL information collection request to the
requirements of 35 U.S.C. 209 and 37
TRADE COMMISSION Office of Management and Budget
CFR part 404.
Complete applications for a license in (OMB) for review and approval in
[USITC SE–17–028]
the prospective field of use that are filed accordance with the Paperwork
in response to this notice will be treated Sunshine Act Meeting Reduction Act of 1995. The proposed
as objections to the grant of the information collection was previously
sradovich on DSK3GMQ082PROD with NOTICES

contemplated Exclusive Patent License AGENCY HOLDING THE MEETING: United published on May 18, 2017, allowing for
Agreement. Comments and objections States International Trade Commission. a 60 day comment period.
submitted to this notice will not be TIME AND DATE: July 14, 2017 at 11:00 DATES: Comments are encouraged and
made available for public inspection a.m. will be accepted for 30 days until
and, to the extent permitted by law, will PLACE: Room 101, 500 E Street SW., August 9, 2017.
not be released under the Freedom of Washington, DC 20436, Telephone: FOR FURTHER INFORMATION CONTACT:
Information Act, 5 U.S.C. 552. (202) 205–2000. Written comments and/or suggestion

VerDate Sep<11>2014 16:08 Jul 07, 2017 Jkt 241001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\10JYN1.SGM 10JYN1

Document Created: 2017-07-08 00:55:38
Document Modified: 2017-07-08 00:55:38

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 12, 2017 at 11:00 a.m.
FR Citation		82 FR 31784